• International Consensus on the Use of Genetics in the Management of Hereditary Angioedema 

      Germenis A.E., Margaglione M., Pesquero J.B., Farkas H., Cichon S., Csuka D., Lera A.L., Rijavec M., Jolles S., Szilagyi A., Trascasa M.L., Veronez C.L., Drouet C., Zamanakou M., Andrejevic S., Aygören-Pürsün E., Bara N.-A., Bernstein J., Bork K., Bouillet L., Bova M., Boysen H.H., Bygum A., Caballero T., Castaldo A., Christiansen S., Cicardi M., Fabiani J., Katelaris C., Dewald G., Gökmen N.M., Gonzalez-Quevedo M.T., Gooi J., Grivcheva-Panovska V., Grumach A., Hakl R., Hardy G., Jesenak M., Kaplan A., Kirschfink M., Köhalmi K.V., Leibovich I., Longhurst H.J., Lumry W., Magerl M., Saguer I.M., Nagy I.B., Nieto S., Nordenfelt P., Porębski G., Psarros F., Reshef A., Riedl M.A., Sheikh F., Peter S., Speletas M., Staevska M., Stobiecki M., Triggiani M., Veszeli N., Waserman S., Weber C., Wuillemin W., Zuraw B. (2020)
      Hereditary angioedema (HAE) is becoming much more genetically complex than was initially considered. Thus, the role of HAE genetics is expanding beyond research laboratories, and the genotyping of subjects suffering from ...
    • A Prospective Validation of the Updated Movement Disorders Society Research Criteria for Prodromal Parkinson's Disease 

      Giagkou N., Maraki M.I., Yannakoulia M., Kosmidis M.H., Dardiotis E., Hadjigeorgiou G.M., Sakka P., Ntanasi E., Anastasiou C.A., Xiromerisiou G., Stefanis L., Scarmeas N., Stamelou M. (2020)
      Objective: The objective of this study was to validate the recently updated research criteria for prodromal Parkinson's disease (pPD) proposed by the International Parkinson's Disease and Movement Disorders Society. Methods: ...
    • Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement 

      Rikos D., Dardiotis E., Tsivgoulis G., Zintzaras E., Hadjigeorgiou G.M. (2016)
      Background Randomized controlled trials (RCTs) are the best tool to evaluate the effectiveness of clinical interventions. The CONSORT (Consolidated Standards of Reporting Trials) statement is an evidence-based approach to ...
    • Review and update of the concept of embolic stroke of undetermined source 

      Diener H.-C., Easton J.D., Hart R.G., Kasner S., Kamel H., Ntaios G. (2022)
      Ischaemic strokes have traditionally been classified according to the TOAST criteria, in which strokes with unclear aetiology are classified as cryptogenic strokes. However, the definition of cryptogenic stroke did not ...
    • Simulation to minimise patient self-inflicted lung injury: are we almost there? 

      Tsolaki V., Zakynthinos G.E. (2022)
      Computational modelling has been used to enlighten pathophysiological issues in patients with acute respiratory distress syndrome (ARDS) using a sophisticated, integrated cardiopulmonary model. COVID-19 ARDS is a ...
    • Unravelling data for rapid evidence-based response to COVID-19: A summary of the unCoVer protocol 

      Peñalvo J.L., Mertens E., Ademović E., Akgun S., Baltazar A.L., Buonfrate D., Ĝ Oklo M., Devleesschauwer B., DIaz Valencia P.A., Fernandes J.C., Gómez E.J., Hynds P., Kabir Z., Klein J., Kostoulas P., Llanos Jiménez L., Lotrean L.M., Majdan M., Menasalvas E., Nguewa P., Oh I.-H., O'Sullivan G., Pereira D.M., Reina Ortiz M., Riva S., Soriano G., Soriano J.B., Spilki F., Tamang M.E., Trofor A.C., Vaillant M., Van Ierssel S., Vuković J., Castellano J.M. (2021)
      Introduction unCoVer - Unravelling data for rapid evidence-based response to COVID-19 - is a Horizon 2020-funded network of 29 partners from 18 countries capable of collecting and using real-world data (RWD) derived from ...